TY - JOUR
T1 - Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA
AU - Bozkurt, Murat Fani
AU - Virgolini, Irene
AU - Balogova, Sona
AU - Beheshti, Mohsen
AU - Rubello, Domenico
AU - Decristoforo, Clemens
AU - Ambrosini, Valentina
AU - Kjaer, Andreas
AU - Delgado-Bolton, Roberto
AU - Kunikowska, Jolanta
AU - Oyen, Wim J G
AU - Chiti, Arturo
AU - Giammarile, Francesco
AU - Fanti, Stefano
PY - 2017/8
Y1 - 2017/8
N2 - PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
AB - PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
KW - Dihydroxyphenylalanine/analogs & derivatives
KW - Gallium Radioisotopes
KW - Heterocyclic Compounds, 1-Ring/chemistry
KW - Humans
KW - Image Interpretation, Computer-Assisted
KW - Neuroendocrine Tumors/diagnostic imaging
KW - Peptides/chemistry
KW - Positron Emission Tomography Computed Tomography/methods
KW - Practice Guidelines as Topic
KW - Quality Control
KW - Receptors, Somatostatin/metabolism
KW - Tissue Distribution
UR - https://link.springer.com/article/10.1007%2Fs00259-017-3807-0
U2 - 10.1007/s00259-017-3728-y
DO - 10.1007/s00259-017-3728-y
M3 - Journal article
C2 - 28547177
VL - 44
SP - 1588
EP - 1601
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
SN - 1619-7070
IS - 9
ER -